# Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Knee Osteoarthritis

> **NCT05526898** · NA · UNKNOWN · sponsor: **Syntr Health Technologies, Inc.** · enrollment: 176 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DEVICE:** SyntrFuge System
- **DRUG:** Triamcinolone Injection

## Key facts

- **NCT ID:** NCT05526898
- **Lead sponsor:** Syntr Health Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-10-01
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 176 (ESTIMATED)
- **Last updated:** 2024-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05526898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05526898, "Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Knee Osteoarthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05526898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*